Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 886982 NEW YORK, NY
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$46,745,096
+$15,905,333 QoQ
Shares Held
742,693
+68.9% QoQ
Ownership
1.69%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#17
of 256 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. TARS ranks #69 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in TARS

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $46,745,096 742,693
2026-03-31 $30,839,763 439,626
2025-12-31 $31,008,282 378,704
2025-09-30 $20,266,342 341,012
2025-06-30 $16,122,736 397,994
2025-03-31 $15,488,568 301,510
2024-12-31 $17,648,079 318,730
2024-09-30 $8,840,009 268,775
2024-06-30 $5,586,875 205,551
2024-03-31 $7,405,584 203,730
2023-12-31 $4,808,139 237,439
2023-09-30 $1,778,101 100,062
2023-06-30 $1,390,522 76,952
2023-03-31 $359,062 28,565
2022-12-31 $816,092 55,668
2022-09-30 $1,861,422 108,728
2022-06-30 $1,441,166 98,710
2022-03-31 $475,265 28,256
2021-12-31 $632,317 28,103
2021-09-30 $570,644 26,480
2021-06-30 $778,982 26,880
2021-03-31 $934,476 28,994